Cargando…
RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells
BACKGROUND: Cisplatin is one of the most commonly used chemotherapy agent for lung cancer. The therapeutic efficacy of cisplatin is limited by the development of resistance. In this study, we test the effect of RNA interference (RNAi) targeting Fanconi anemia (FA)/BRCA pathway upstream genes on the...
Autores principales: | Dai, Chun-Hua, Li, Jian, Chen, Ping, Jiang, He-Guo, Wu, Ming, Chen, Yong-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575453/ https://www.ncbi.nlm.nih.gov/pubmed/26385482 http://dx.doi.org/10.1186/s12929-015-0185-4 |
Ejemplares similares
-
Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin
por: Burkitt, Kyunghee, et al.
Publicado: (2008) -
Cooperation of the NEIL3 and Fanconi anemia/BRCA pathways in interstrand crosslink repair
por: Li, Niu, et al.
Publicado: (2020) -
Bcr/Abl Interferes with the Fanconi Anemia/BRCA Pathway: Implications in the Chromosomal Instability of Chronic Myeloid Leukemia Cells
por: Valeri, Antonio, et al.
Publicado: (2010) -
Inhibition of USP28 overcomes Cisplatin-resistance of squamous tumors by suppression of the Fanconi anemia pathway
por: Prieto-Garcia, Cristian, et al.
Publicado: (2021) -
Mutated Fanconi anemia pathway in non-Fanconi anemia cancers
por: Shen, Yihang, et al.
Publicado: (2015)